Marshall Ma spent over 20 years in China and UK top university research institutes and commercial organizations after he graduated in Universities in China and UK and received his second master’s degree from Manchester University.

Mr. Marshall Ma has worked on many UK/EU and China biopharmaceutical research partnership projects by bridging the gaps and overcoming barriers to forge successful alliance. Marshall successfully helped organisations, research institutes, companies in UK and China to minimize the cost and maximize the research value, help the new technology products successful launch to the market. His technology transfer consultant works cover a wide range of products and technology field including small molecule oncology therapeutics, gene therapeutics, vaccine platform technologies, natural products for common cold and allergic rhinitis, drug delivery technologies, continuous blood glucose monitoring technology and nutraceutical products etc.

His passion for successful partnership deals between UK/EU and China life science companies is driven by his strong commitment and strategic vision of developing and supplying cutting edge technology derived novel therapeutics for the prevention and treatment of prevalent diseases around the world at a level of cost which can be affordable not only by the rich nations but most importantly accessible by the developing nations around the world.